← TrialMatch
HomeTrials

Multidisciplinary Approach to Fatigue

Prospective longitudinal, single-center, non-randomized study for the implementation of an integrated multidisciplinary fatigue follow-up for young patients with breast cancer or germ cell tumour

Condition(s)Breast Cancer, Germ Cell Tumor
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryProspective longitudinal, single-center, non-randomized study for the implementation of an integrated multidisciplinary fatigue follow-up for young patients with breast cancer or germ cell tumour
Who can participateInclusion Criteria: * Age between 18 and 39 years at the time of signing the informed consent * Patient who speaks and understands French * Signed study informed consent form obtained prior to any study related procedures * At minimum, a moderate (\>3) fatigue level according to the Standard Rating Scale (NRS) 1 month after completion of acute treatment; as measured at the Survivorship of the standard program * Patient with either: curative breast cancer (AJCC stage I-II-III) or a germ cell tumor Exclusion Criteria: * Refusal to participate in the study * Patient having chosen to participate in another psychosocial intervention study for the duration of the study. * Patients with AJCC stage IV breast cancer
Ages18 Years to 39 Years
SexAll
Lead sponsorJules Bordet Institute
LocationsBrussels, Belgium
Start date2022-08-19
NCT IDNCT05502224
Official listinghttps://clinicaltrials.gov/study/NCT05502224

🔍 Search all trials →